Publications by authors named "I Gal"

Introduction: The terror attack on October 7, 2023, in southern Israel resulted in approximately 1,200 civilians and security personnel killed. Of the civilians murdered, approximately 200 men, women, and children were murdered inside their homes, while the remaining casualties were murdered in an open field at a music festival, in their cars, or in the streets of local cities.

Materials And Methods: Currently, official data have not yet been published regarding the types of injuries suffered by Israeli civilians during the terror attack.

View Article and Find Full Text PDF

New antimalarial combination therapies with novel modes of action are required to counter the emergence and spread of drug resistance against existing therapeutics. Here, we present a study to evaluate the preventive activity of a combination of clinical antimalarial drug candidates, cabamiquine and ganaplacide, that have multistage activity against the liver and blood stages of infection. Cabamiquine (DDD107498, M5717) inhibits parasite protein synthesis, and ganaplacide (KAF156) inhibits protein trafficking, blocks the establishment of new permeation pathways, and causes endoplasmic reticulum expansion.

View Article and Find Full Text PDF

This paper presents a comparative study of entropy estimation in a large-alphabet regime. A variety of entropy estimators have been proposed over the years, where each estimator is designed for a different setup with its own strengths and caveats. As a consequence, no estimator is known to be universally better than the others.

View Article and Find Full Text PDF

The paper addresses the problem of distinguishing the leading agents in the group. The problem is considered in the framework of classification problems, where the agents in the group select the items with respect to certain properties. The suggested method of distinguishing the leading agents utilizes the connectivity between the agents and the Rokhlin distance between the subgroups of the agents.

View Article and Find Full Text PDF

Current global COVID-19 booster scheduling strategies mainly focus on vaccinating high-risk populations at predetermined intervals. However, these strategies overlook key data: the direct insights into individual immunity levels from active serological testing and the indirect information available either through sample-based sero-surveillance, or vital demographic, location, and epidemiological factors. Our research, employing an age-, risk-, and region-structured mathematical model of disease transmission-based on COVID-19 incidence and vaccination data from Israel between 15 May 2020 and 25 October 2021-reveals that a more comprehensive strategy integrating these elements can significantly reduce COVID-19 hospitalizations without increasing existing booster coverage.

View Article and Find Full Text PDF